Komori
Presentation materials on financial results6340SHIBUYA CORPORATIONMachinery

Financial Results Presentation for the Fiscal Year Ended June 2025

2025年6月期は売上高・利益が過去最高となり、期初計画も上回った。一方、2026年6月期は売上高の増加を見込むものの、固定費や素材・エネルギー価格の上昇などにより減益を予想している。

Worth reading
74In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-749
百万円（2026年6月期営業利益の前期比増減額）
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials on financial resultsFiscal year ended June 202516 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥129,017 million+11.8%
Operating profit¥13,749 million+2.7%
Ordinary income¥13,773 million+1.6%
Net income¥10,052 million +2.8%net profit attributable to owners of the parent
Gross Profit Margin19.5 %
Operating profit margin10.7 %
Selling, general and administrative expenses¥11,457 million
Full-year earnings forecast
Fiscal Period CoveredFiscal year ending June 2026
Net Sales
¥133,000 million
Operating profit
¥13,000 million
Ordinary income
¥13,200 million
Net income
¥9,300 million net profit attributable to owners of the parent
EPS
¥336.1
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
2025年6月期は期初計画に対して増収増益を達成
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Increase in gross profit from higher sales¥2,868 million
  • Decline in Gross Profit Margin¥-1,132 million
  • Increase in SG&A expenses¥-762 million
  • Increase in R&D expenses¥-606 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
固定費、人件費、償却費、素材・エネルギー価格、プラントのプロダクトミックスについて定性的に記載。数値前提はNot disclosed
New initiatives
  • 新型2段殺菌システムの出荷
  • ライン式ウェイトフィラ・キャッパの新開発
  • 固液混合分散システムの製品化
  • 自家細胞バンク向け自動細胞培養システムの受注・製作
  • インドネシア法人、インド営業事務所、米国サービス拠点の設立・設置
  • 上海の医療機器組立工場法人の設立
  • End-to-end manufacturing DX project
  • Production capacity expansion investments at 4 plants
  • 2026年6月期のスマートファクトリー、3D実装ボンダ、フードテック技術の開発
Key KPIsA metric the company considers important as a management benchmark.
  • EPS¥363.3
    Year on year against the same period last year+2.8%
  • ROE9.6 %
    Year on year against the same period last year-0.6%
  • Domestic revenue¥75,626 million
    Year on year against the same period last year+6.4%
  • Overseas revenue¥53,390 million
    Year on year against the same period last year+20.4%
  • Orders received¥120,367 million
    Year on year against the same period last year-9.6%
  • Order backlog¥93,179 million
    Year on year against the same period last year-8.5%
Segment results
Packaging Plants
Net Sales
¥80,081 million+21.3%
Operating profit
¥12,574 million+16.1%
Mechatronics Systems
Net Sales
¥37,765 million+2.1%
Operating profit
¥2,341 million-28.0%
Agricultural Equipment
Net Sales
¥11,170 million-10.1%
Operating profit
¥1,042 million-30.7%
Medium-term management plan targets
Fiscal year ending June 2027
Net Sales¥150,000 million
Operating profit¥16,000 million
Unit_Operating profit¥ million
2030
Net Sales¥200,000 million
2025年6月期実績との対比売上高は1290億円、営業利益は137億円で、2025年6月期目標を達成
Financial targets
ROE target10% or higher
Actual ROE9.6%
Market Size / Share
  • PETボトル飲料のグローバル市場2033年まで年平均5%程度の成長見込み
  • Global dialysis market1,744 US$100 million
    Base year2,030
  • Advanced semiconductors for data centers56 US$100 million
    Base year2,027
Orders received and order backlog
Orders received
¥120,367 million
Year on year against the same period last year-9.6%
Order backlog
¥93,179 million
Year on year against the same period last year-8.5%
Number of stores and locations
海外営業・サービス拠点の設立・設置は記載されているが、店舗数・拠点数の期末総数および期中の出退数はNot disclosed
Number of employees
Changes during the period and hiring planインドからの採用実績は2024年6月期10名、2025年6月期8名、2026年6月期20名内定
Capital expenditures
¥7,143 million
Annual Dividend
Fiscal year ended June 2025
Annual¥95 per share
Forecast for the fiscal year ending June 2026
Interim¥47.5 per share
End of period¥47.5 per share
Annual¥95 per share
Payout ratio
Fiscal year ended June 202526.1 %
Forecast for the fiscal year ending June 202628.3 %
Medium-term target2027年6月期に30%以上
Acquisition of treasury shares
機動的に実施する方針。取得枠の金額・株数・期間はNot disclosed
Contents of this document
ItemDetails
Document typePresentation materials on financial results
Fiscal Period CoveredFiscal year ended June 2025
Net Sales¥129,017 million (YoY +11.8%)
Operating profit¥13,749 million (YoY +2.7%)
Ordinary income¥13,773 million (YoY +1.6%)
Net income¥10,052 million (net profit attributable to owners of the parent) (YoY +2.8%)
Gross Profit Margin19.5 %
Operating profit margin10.7 %
Selling, general and administrative expenses¥11,457 million
Full-year earnings forecastFiscal Period Covered Fiscal year ending June 2026 / Net Sales ¥133,000 million / Operating profit ¥13,000 million / Ordinary income ¥13,200 million / Net income ¥9,300 million (net profit attributable to owners of the parent) / EPS ¥336.1
Self-assessment against the plan2025年6月期は期初計画に対して増収増益を達成
Segment resultsPackaging Plants Net Sales ¥80,081 million (YoY +21.3%) / Operating profit ¥12,574 million (YoY +16.1%) / Mechatronics Systems Net Sales ¥37,765 million (YoY +2.1%) / Operating profit ¥2,341 million (YoY -28.0%) / Agricultural Equipment Net Sales ¥11,170 million (YoY -10.1%) / Operating profit ¥1,042 million (YoY -30.7%)
Breakdown of Factors Affecting the ChangeFactors Increase in gross profit from higher sales / Amount ¥2,868 million, Factors Decline in Gross Profit Margin / Amount ¥-1,132 million, Factors Increase in SG&A expenses / Amount ¥-762 million, Factors Increase in R&D expenses / Amount ¥-606 million
Key KPIsIndicator name EPS / Value ¥363.3 / Year on year against the same period last year ¥2.8, Indicator name ROE / Value 9.6 % / Year on year against the same period last year -0.6 %, Indicator name Domestic revenue / Value ¥75,626 million / Year on year against the same period last year ¥6.4 million, Indicator name Overseas revenue / Value ¥53,390 million / Year on year against the same period last year ¥20.4 million, Indicator name Orders received / Value ¥120,367 million / Year on year against the same period last year ¥-9.6 million, Indicator name Order backlog / Value ¥93,179 million / Year on year against the same period last year ¥-8.5 million
Number of stores and locations海外営業・サービス拠点の設立・設置は記載されているが、店舗数・拠点数の期末総数および期中の出退数はNot disclosed
Number of employeesNumber of Employees Not disclosed / Changes during the period and hiring plan インドからの採用実績は2024年6月期10名、2025年6月期8名、2026年6月期20名内定
Assumptions Underlying the Business Outlook固定費、人件費、償却費、素材・エネルギー価格、プラントのプロダクトミックスについて定性的に記載。数値前提はNot disclosed
Medium-term management plan targetsFiscal year ending June 2027 Net Sales ¥150,000 million / Operating profit ¥16,000 million / Unit_Operating profit ¥ million / 2030 Net Sales ¥200,000 million / 2025年6月期実績との対比 売上高は1290億円、営業利益は137億円で、2025年6月期目標を達成
Financial targetsROE target 10% or higher / Actual ROE 9.6%
Annual DividendFiscal year ended June 2025 Annual ¥95 per share / Forecast for the fiscal year ending June 2026 Interim ¥47.5 per share / End of period ¥47.5 per share / Annual ¥95 per share
Payout ratioFiscal year ended June 2025 26.1 % / Forecast for the fiscal year ending June 2026 28.3 % / Medium-term target 2027年6月期に30%以上
Acquisition of treasury shares機動的に実施する方針。取得枠の金額・株数・期間はNot disclosed
Capital expenditures¥7,143 million
Orders received and order backlogOrders received ¥120,367 million / Order backlog ¥93,179 million
Market Size / ShareMarket PETボトル飲料のグローバル市場 / Value 2033年まで年平均5%程度の成長見込み, Market Global dialysis market / Value 1,744 US$100 million / Base year 2,030 US$100 million, Market Advanced semiconductors for data centers / Value 56 US$100 million / Base year 2,027 US$100 million
New initiatives新型2段殺菌システムの出荷, ライン式ウェイトフィラ・キャッパの新開発, 固液混合分散システムの製品化, 自家細胞バンク向け自動細胞培養システムの受注・製作, インドネシア法人、インド営業事務所、米国サービス拠点の設立・設置, 上海の医療機器組立工場法人の設立, End-to-end manufacturing DX project, Production capacity expansion investments at 4 plants, 2026年6月期のスマートファクトリー、3D実装ボンダ、フードテック技術の開発
Items this document does not state (5)
Results for the three months of the current quarterProgress against full-year forecastUnit price and quantity metricsRisk amount incorporated into the outlookKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

2025年6月期はパッケージングプラント事業が大きく伸長したことが、期初計画を上回る増収増益の理由とされている。2026年6月期の減益要因として、人件費・償却費などの固定費増加、素材・エネルギー価格の上昇、プラントのプロダクトミックスが挙げられている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Presentation for the Fiscal Year Ended June 2025 | SHIBUYA CORPORATION (6340) timely disclosure | Komori